Trading Symbol
CHCL
Cian Healthcare Limited has scheduled a meeting of its Board of Directors for Friday, November 13, 2026. The primary agenda of the meeting is to consider and approve the unaudited financial results for the half year ended September 30, 2026, covering both standalone and consolidated financial statements.
The disclosure is made pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulations 30 and 33 and other applicable regulations.
In continuation of the company's previous communication (Ref. No.: CIAN/BSE/2026-27/25 dated September 22, 2026), the trading window for dealing in securities of the company remains closed for all Designated Persons and their immediate relatives. The closure period began on October 1, 2026, and will continue until 48 hours after the declaration of the unaudited financial results.
The trading window closure is implemented in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (as amended) and the company's Prohibition of Insider Trading Code.
The intimation has been submitted to BSE Limited and is also being filed in XBRL mode.